Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers I: Abeta 42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive Deficits-Reference-Cited by-同舟云学术

Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers I: Abeta 42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive Deficits

Published:2014-11-12 Issue:11 Volume:9 Page:e111898
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Izzo Nicholas J.,Staniszewski Agnes,To Lillian,Fa Mauro,Teich Andrew F.,Saeed Faisal,Wostein Harrison,Walko Thomas,Vaswani Anisha,Wardius Meghan,Syed Zanobia,Ravenscroft Jessica,Mozzoni Kelsie,Silky Colleen,Rehak Courtney,Yurko Raymond,Finn Patricia,Look Gary,Rishton Gilbert,Safferstein Hank,Miller Miles,Johanson Conrad,Stopa Edward,Windisch Manfred,Hutter-Paier Birgit,Shamloo Mehrdad,Arancio Ottavio,LeVine Harry,Catalano Susan M.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference74 articles.

1. Detection of a biomarker for Alzheimer's disease from synthetic and clinical samples using a nanoscale optical biosensor;AJ Haes;J Am Chem Soc,2005

2. Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction;JL Tomic;Neurobiol Dis,2009

3. Bao F, Wicklund L, Lacor PN, Klein WL, Nordberg A, et al.. (2012) Different beta-amyloid oligomer assemblies in Alzheimer brains correlate with age of disease onset and impaired cholinergic activity. Neurobiol Aging 33: : 825 e821–813.

4. Amyloid-beta oligomerization in Alzheimer dementia versus high-pathology controls;TJ Esparza;Ann Neurol,2013

5. New ELISAs with high specificity for soluble oligomers of amyloid beta-protein detect natural Abeta oligomers in human brain but not CSF;T Yang;Alzheimers Dement,2013

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An interim exploratory proteomics biomarker analysis of a phase 2 clinical trial to assess the impact of CT1812 in Alzheimer's disease;Neurobiology of Disease;2024-09

2. CT1812 biomarker signature from a meta‐analysis of CSF proteomic findings from two Phase 2 clinical trials in Alzheimer's disease;Alzheimer's & Dementia;2024-08-21

3. Structure-Affinity relationships of novel σ2R/TMEM97 ligands;Bioorganic Chemistry;2024-04

4. Glitches in the brain: the dangerous relationship between radiotherapy and brain fog;Frontiers in Cellular Neuroscience;2024-03-07

5. Current status of PET tracers for the early diagnosis of Alzheimer's disease;TrAC Trends in Analytical Chemistry;2024-03